| MPSI-MSCa | NIH3T3b |
---|
| MOI 5.2 | MOI 77 | G418 |
---|
| IDUA (U) c | GFP (%)d | IDUA (U)c | GFP (%)d | IDUA (U)c | GFP (%)d |
---|
Control | ND | NE | ND | NE | 23.8 ± 5.8 | 0 |
MLV-GFP | NE | NE | 20.7 ± 21.6 | NE | 29.5 ± 29.5 | 100 |
1w (I/G) | 2278 ± 249 | 8.9 ± 1.3 | 5340.4 ± 137.0 | 21.3 ± 6.6 | NE | NE |
3-4w (I/G) | 3016.5 ± 780 | 9.3 ± 2.2 | 59.7 ± 16.8 | ND | 5849.1 ± 851.6 | 100 |
6w (I/G) | 15 ± 1.4 | ND | NE | ND | NE | NE |
- a MPSI-MSC were transduced with 5.2 or 77 MOI of MLV vectors and evaluated for transgene expression during 6 weeks; b NIH3T3 cells were transduced with MLV vectors and selected with G418 (these cells were used as a positive control cells); ND = non detectable; NE = non-evaluated; w = week; c IDUA activity is expressed in units of activity (nmols/h/mg of protein); d GFP-positive cells are expressed in percentage. All experiments were performed at least in duplicates. (I/G) means to monitor expression of IDUA or GFP, MSC were transduced with MLV-IDUA or MLV-GFP, respectively.